The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118721532 11872153 2 F 201203 20160727 20151228 20160803 EXP US-PFIZER INC-2015464187 PFIZER 57.00 YR F Y 100.00000 KG 20160803 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118721532 11872153 1 PS DILANTIN PHENYTOIN 1 7 DF, DAILY; 100 MG CAPSULE 7 PER DAY; 3 IN MORNING AND 4 IN EVENING L57545 84349 700 MG CAPSULE, HARD
118721532 11872153 2 SS EFFEXOR XR VENLAFAXINE HYDROCHLORIDE 1 Oral 75 MG, 1X/DAY IN EVENING L51534 20699 75 MG PROLONGED-RELEASE CAPSULE QD
118721532 11872153 3 SS EFFEXOR XR VENLAFAXINE HYDROCHLORIDE 1 20699 PROLONGED-RELEASE CAPSULE
118721532 11872153 4 C PHENOBARBITAL. PHENOBARBITAL 1 100 MG, UNK 0 100 MG
118721532 11872153 5 C METOPROLOL. METOPROLOL 1 100 MG, 2X/DAY 0 100 MG TABLET BID
118721532 11872153 6 C LISINOPRIL. LISINOPRIL 1 20 MG, 2X/DAY 0 20 MG TABLET BID
118721532 11872153 7 C FENOFIBRATE. FENOFIBRATE 1 135 MG, 1X/DAY 0 135 MG TABLET QD
118721532 11872153 8 C FENOFIBRATE. FENOFIBRATE 1 0 TABLET
118721532 11872153 9 C FENOFIBRATE. FENOFIBRATE 1 0 TABLET
118721532 11872153 10 C DEXILANT DEXLANSOPRAZOLE 1 60 MG, 1X/DAY IN MORNING 0 60 MG QD
118721532 11872153 11 C DEXILANT DEXLANSOPRAZOLE 1 0
118721532 11872153 12 C OXYBUTYNIN OXYBUTYNIN 1 5 MG, 1X/DAY 0 5 MG TABLET QD
118721532 11872153 13 C FUROSEMIDE. FUROSEMIDE 1 40 MG, 1X/DAY 0 40 MG TABLET QD
118721532 11872153 14 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 100 UG, MONTHLY 0 100 UG INJECTION /month
118721532 11872153 15 C NITROFURANTOIN MACROCRYSTALS NITROFURANTOIN 1 50 MG, UNK 0 50 MG CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118721532 11872153 1 Generalised tonic-clonic seizure
118721532 11872153 2 Anxiety
118721532 11872153 3 Stress
118721532 11872153 4 Seizure
118721532 11872153 5 Hypertension
118721532 11872153 6 Hypertension
118721532 11872153 7 Blood triglycerides increased
118721532 11872153 8 Blood cholesterol abnormal
118721532 11872153 9 Cerebrovascular accident prophylaxis
118721532 11872153 10 Gastrooesophageal reflux disease
118721532 11872153 11 Gastrooesophageal reflux disease
118721532 11872153 12 Micturition urgency
118721532 11872153 15 Urinary tract infection

Outcome of event

Event ID CASEID OUTC COD
118721532 11872153 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
118721532 11872153 Atrial fibrillation
118721532 11872153 Condition aggravated
118721532 11872153 Heart rate decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118721532 11872153 1 1972 0
118721532 11872153 2 2009 0
118721532 11872153 14 2015 0